Netripples Software Ltd successfully concluded its 32nd Annual General Meeting, where shareholders unanimously approved all board proposals. Key highlights include the adoption of FY2025-26 financials and a strategic plan to address the current BSE trading suspension. The company reported a modest rise in revenue to Rs 7.18 crore and net profit to Rs 2.72 lakh, while maintaining a zero-debt status. The primary focus remains on aligning with SEBI compliance standards to restore liquidity for investors.
Netripples Software AGM Concludes With Strategy to Revoke Trading Suspension
Revenue grew to Rs 7.18 crore in FY26 compared to Rs 6.27 crore in FY25.
Net profit increased to Rs 2.72 lakh from Rs 2.10 lakh in the previous fiscal year.
Reader Takeaway: Zero-debt financials offer stability, but the critical path hinges on resolving the active BSE trading suspension.
What just happened
Netripples Software held its 32nd Annual General Meeting on September 30, 2026. Shareholders unanimously approved all four agenda items, including the adoption of audited financial statements, the re-appointment of M/s. BGS and Associates as statutory auditors, and a strategic roadmap to address the temporary suspension of its equity shares on the BSE.
Why this matters
The company’s primary concern for shareholders is the current suspension of trading on the BSE. By obtaining shareholder approval for specific strategic measures and compliance alignment, management has initiated the formal process to engage with the exchange for a potential trading resumption. Restoring liquidity is the central priority for the board.
Financial and Operating Performance
The company reported steady growth in its operations. Revenue rose to Rs 7.18 crore for FY 2025-26, up from Rs 6.27 crore in the prior year. Net profit stood at Rs 2.72 lakh, marking a slight increase over the Rs 2.10 lakh recorded in FY 2024-25. The firm continues to operate as a zero-debt entity with a specialized focus on SME healthcare e-commerce, maintaining a portfolio of over 75 products.
Risks to watch
While the company has moved to address regulatory requirements, the actual revocation of the trading suspension remains subject to rigorous BSE approval and ongoing adherence to updated SEBI reporting formats. There is no guaranteed timeline for when trading will resume.
What to track next
Investors should monitor future BSE filings for updates on compliance progress and any official communications from the exchange regarding the revocation of the trading suspension.